A Phase 1, Open-label Study to Evaluate the Relative Bioavailability of Two Formulations of BIIB074 and to Assess the Effect of Food on BIIB074 Pharmacokinetics in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Raxatrigine (Primary)
- Indications Neuropathic pain; Trigeminal neuralgia
- Focus Pharmacokinetics
- Sponsors Biogen
- 23 Feb 2017 Status changed from active, no longer recruiting to completed.
- 31 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Feb 2017.